I will say that the fact that both HL and Eastern have not sold out to this point speaks volumes IMO that something substantial with the CVD  CKD or cognitive data will get  to full commercialization at some point once the FDA gives us a green light to move forward, Plus any type of deal with a BP,

I think HL and Eastern have been given more information than us retail shareholders that gives me comfort to hold on till things come together